跳至主要内容
临床试验/NL-OMON56071
NL-OMON56071
已完成
不适用

A randomized controlled trial on the visual function after bilateral implantation of two novel Extended Depth-of-Focus intraocular lenses. - Vario-NL Study

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 32 人待定

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Cataract
发起方
Medisch Universitair Ziekenhuis Maastricht
入组人数
32
状态
已完成
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
去年
研究类型
Interventional

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

入排标准

入选标准

  • \- Minimum 18 years of age
  • \- Bilateral cataract
  • \- Bilateral implantation of either Acunex® Vario IOL or the Alcon AcrySof® IQ
  • Vivity® IOL
  • \- Expected postoperative astigmatism \<\= 1\.00 D (use of femtosecond laser
  • assisted cataract surgery (FLACS) astigmatic keratotomies (AKs) tolerated up to
  • 1\.5 D of corneal astigmatism preoperative)
  • \- Bilateral implantation of a non\-toric Acunex® Vario IOL or a non\-toric Alcon
  • AcrySof® IQ Vivity® IOL
  • \- IOL power calculation between \+10\.00 D and \+30\.0 D

排除标准

  • \- Previous corneal surgery and/or reshaping
  • \- Corneal pathology (i.e., fuchs endothelial dystrophy (FED), irregular
  • astigmatism, herpes simplex virus (HSV) keratitis
  • \- Extensive age\-related macular degeneration (atrophic or exudative age\-related
  • macular degeneration or numerous soft drusen) and post\-intravitreal injection
  • \- Extensive visual field loss (eg. glaucoma, cerebral vascular accident (CVA),
  • hemianopsia, etc.)
  • \- Extensive diabetic retinopathy
  • \- Amblyopia, strabismus, diplopia
  • \- Pseudo exfoliation syndrome or other capsule or zonular abnormalities that

结局指标

主要结局

未指定

相似试验